Exton, PA, United States of America

Nalin L Subasinghe



 

Average Co-Inventor Count = 3.2

ph-index = 3

Forward Citations = 34(Granted Patents)


Company Filing History:


Years Active: 2008-2022

Loading Chart...
Loading Chart...
Loading Chart...
11 patents (USPTO):Explore Patents

Title: **Nalin L Subasinghe: Innovator in Pharmaceutical Research**

Introduction

Nalin L Subasinghe, based in Exton, Pennsylvania, has made significant contributions to the field of pharmaceutical innovation with a total of 11 patents to his name. His work primarily focuses on the development of novel compounds that can potentially improve the treatment of widely prevalent health disorders, particularly those related to metabolic conditions.

Latest Patents

Among his latest patents, Subasinghe has developed benzo-fused heterocyclic derivatives that serve as agonists of GPR120. These compounds have promising applications in treating disorders modulated by GPR120, with a particular emphasis on Type II diabetes mellitus. His inventions include pharmaceutical compositions that incorporate these derivatives, highlighting their potential in enhancing therapeutic outcomes for patients suffering from this chronic condition.

Career Highlights

Nalin L Subasinghe currently works for Janssen Pharmaceutica NV, a leading company in the pharmaceutical industry known for its commitment to improving health through innovation. His expertise and dedication to research have played a crucial role in advancing the company's pharmaceutical offerings and shaping effective treatment protocols for metabolic diseases.

Collaborations

Throughout his career, Subasinghe has collaborated with talented colleagues, including Zhihua Sui and James C Lanter. These partnerships have fostered a dynamic research environment, enabling them to combine their expertise and insights for the development of new and effective therapeutic solutions.

Conclusion

In summary, Nalin L Subasinghe is a prominent inventor whose contributions to pharmaceuticals have had a meaningful impact on the treatment of metabolic disorders. With an impressive portfolio of patents and ongoing collaborations within the industry, he continues to push the boundaries of innovation in medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…